EMPAGLIFLOZIN

EMPAGLIFLOZIN was reported 69480 times

EMPAGLIFLOZIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT MEDIASTINAL NEOPLASM 58 0.5273
1 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2079 0.5030
2 URINE KETONE BODY 48 0.2945
3 PERINEAL INFECTION 45 0.2273
4 EMPHYSEMATOUS PYELONEPHRITIS 38 0.2077
5 KETOACIDOSIS 1524 0.2034
6 BLOOD KETONE BODY INCREASED 153 0.1959
7 URINARY TRACT CANDIDIASIS 37 0.1937
8 GENITAL INFECTION 63 0.1909
9 GLYCOSYLATED HAEMOGLOBIN 30 0.1695
10 ACETONAEMIA 41 0.1627
11 DIABETIC KETOACIDOSIS 3903 0.1623
12 STARVATION KETOACIDOSIS 31 0.1535
13 BLOOD KETONE BODY 52 0.1499
14 KETONURIA 121 0.1486
15 STEROID DEPENDENCE 124 0.1412
16 CATARRH 123 0.1361
17 BALANOPOSTHITIS 111 0.1350
18 KETOSIS 146 0.1346
19 GENITAL INFECTION FUNGAL 106 0.1283
20 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 142 0.1185
21 GLUCOSE URINE PRESENT 141 0.1108
22 URINE KETONE BODY PRESENT 168 0.1064
23 DIABETIC KETOSIS 37 0.0974
24 PENILE ERYTHEMA 34 0.0907
25 SCROTAL ABSCESS 34 0.0899
26 PERINEAL ABSCESS 40 0.0887
27 PHIMOSIS 61 0.0828
28 GASTROINTESTINAL HYPOMOTILITY 185 0.0820
29 GLYCOSYLATED HAEMOGLOBIN DECREASED 131 0.0813
30 BURNS SECOND DEGREE 130 0.0740
31 GENITAL DISCOMFORT 41 0.0740
32 PRURITUS GENITAL 170 0.0721
33 NECROTISING FASCIITIS 254 0.0720
34 FUNGAL INFECTION 2167 0.0650
35 DIABETIC METABOLIC DECOMPENSATION 80 0.0576
36 GLYCOSURIA 77 0.0570
37 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 76 0.0541
38 PERINEAL PAIN 37 0.0517
39 IMPAIRED GASTRIC EMPTYING 701 0.0514
40 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 56 0.0504
41 GLYCOSYLATED HAEMOGLOBIN INCREASED 1262 0.0500
42 GENITAL SWELLING 34 0.0492
43 GLOMERULAR FILTRATION RATE ABNORMAL 68 0.0480
44 ANION GAP INCREASED 63 0.0471
45 POLYCYTHAEMIA 97 0.0470
46 PRODUCT MONITORING ERROR 66 0.0457
47 VULVOVAGINAL MYCOTIC INFECTION 177 0.0449
48 GLOMERULAR FILTRATION RATE INCREASED 37 0.0448
49 GENITAL RASH 60 0.0420
50 ORCHITIS 45 0.0418
51 VULVOVAGINAL PRURITUS 211 0.0416
52 GENITAL BURNING SENSATION 36 0.0415
53 BRASH SYNDROME 56 0.0399
54 HYPOVOLAEMIA 227 0.0388
55 CARDIAC AMYLOIDOSIS 42 0.0381
56 HAEMATOCRIT INCREASED 87 0.0381
57 HYPOPNOEA 130 0.0374
58 PRERENAL FAILURE 49 0.0348
59 ALCOHOL POISONING 93 0.0347
60 TOE AMPUTATION 176 0.0346
61 CARDIAC FAILURE CHRONIC 145 0.0340
62 BLOOD GLUCOSE ABNORMAL 621 0.0336
63 PENILE SWELLING 41 0.0335
64 AMPUTATION 41 0.0329
65 ABNORMAL LOSS OF WEIGHT 221 0.0324
66 GLOMERULAR FILTRATION RATE DECREASED 391 0.0318
67 HAEMOGLOBIN INCREASED 139 0.0304
68 FOOT AMPUTATION 44 0.0302
69 CAROTID ARTERIOSCLEROSIS 31 0.0300
70 UROSEPSIS 272 0.0295
71 VULVOVAGINAL CANDIDIASIS 39 0.0288
72 BRONCHIECTASIS 193 0.0286
73 ACIDOSIS 216 0.0282
74 OBSTRUCTIVE SLEEP APNOEA SYNDROME 41 0.0281
75 DIABETIC FOOT 85 0.0277
76 LEFT ATRIAL DILATATION 35 0.0274
77 GENITAL PAIN 40 0.0270
78 POLLAKIURIA 1098 0.0263
79 POLYURIA 213 0.0260
80 POLYDIPSIA 101 0.0255
81 URINE OUTPUT INCREASED 66 0.0253
82 BLOOD IMMUNOGLOBULIN E INCREASED 59 0.0243
83 PERIPHERAL ARTERY OCCLUSION 34 0.0242
84 PANCREATITIS NECROTISING 54 0.0235
85 METABOLIC ACIDOSIS 748 0.0234
86 SYSTEMIC CANDIDA 58 0.0231
87 HYPERVOLAEMIA 114 0.0230
88 LACTIC ACIDOSIS 736 0.0227
89 THIRST 393 0.0220
90 GANGRENE 132 0.0219
91 SUBSTANCE USE 34 0.0218
92 PROSTATITIS 66 0.0217
93 DIABETES MELLITUS INADEQUATE CONTROL 367 0.0207
94 PYELONEPHRITIS ACUTE 40 0.0204
95 DIABETIC COMA 57 0.0203
96 DIABETIC RETINOPATHY 69 0.0203
97 URINE ABNORMALITY 89 0.0196
98 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 79 0.0193
99 LEG AMPUTATION 79 0.0192
100 BLOOD GLUCOSE FLUCTUATION 210 0.0191
101 PAROSMIA 143 0.0189
102 GINGIVAL PAIN 148 0.0186
103 MUCOSAL DRYNESS 37 0.0184
104 INSULIN RESISTANCE 38 0.0182
105 HYPERNATRAEMIA 89 0.0178
106 CARDIAC MURMUR 152 0.0175
107 VULVOVAGINAL SWELLING 32 0.0175
108 BLOOD BICARBONATE DECREASED 33 0.0174
109 RED BLOOD CELL COUNT INCREASED 48 0.0174
110 RHINITIS 140 0.0173
111 URINE ODOUR ABNORMAL 102 0.0173
112 DEVICE INFUSION ISSUE 43 0.0173
113 BLOOD GLUCOSE INCREASED 3255 0.0173
114 CARDIAC OPERATION 148 0.0172
115 CARDIAC FAILURE ACUTE 108 0.0162
116 DIABETIC NEUROPATHY 78 0.0157
117 VITAMIN B12 DECREASED 45 0.0156
118 DIZZINESS POSTURAL 151 0.0156
119 PYELONEPHRITIS 133 0.0153
120 DIABETIC NEPHROPATHY 32 0.0145
121 VULVOVAGINAL DISCOMFORT 63 0.0142
122 URINARY HESITATION 34 0.0142
123 HYPERGLYCAEMIA 519 0.0142
124 THROAT CLEARING 53 0.0141
125 ANXIETY DISORDER 47 0.0141
126 BLOOD GLUCOSE DECREASED 674 0.0140
127 DIASTOLIC DYSFUNCTION 43 0.0139
128 HYPOGLYCAEMIA 673 0.0139
129 URINARY TRACT INFECTION BACTERIAL 35 0.0138
130 TROPONIN INCREASED 104 0.0137
131 PHYSICAL DECONDITIONING 35 0.0136
132 HAEMATOLOGICAL INFECTION 33 0.0135
133 CARDIAC FAILURE 1080 0.0134
134 EJECTION FRACTION DECREASED 208 0.0134
135 INFUSION SITE HAEMORRHAGE 44 0.0134
136 PENIS DISORDER 33 0.0133
137 LEFT VENTRICULAR DYSFUNCTION 89 0.0133
138 ISCHAEMIC CARDIOMYOPATHY 40 0.0130
139 VASCULAR GRAFT 37 0.0128
140 MICTURITION URGENCY 146 0.0128
141 HYPERLACTACIDAEMIA 34 0.0127
142 HYPERKALAEMIA 439 0.0125
143 ACUTE KIDNEY INJURY 1898 0.0124
144 BLOOD LACTIC ACID INCREASED 65 0.0123
145 CUTANEOUS VASCULITIS 45 0.0123
146 IMPAIRED QUALITY OF LIFE 177 0.0123
147 DEHYDRATION 1624 0.0122
148 VAGINAL INFECTION 57 0.0121
149 INFUSION SITE PRURITUS 38 0.0120
150 URINARY TRACT INFECTION 2035 0.0119
151 BLOOD PRESSURE SYSTOLIC DECREASED 54 0.0119
152 BLOOD CREATINE INCREASED 52 0.0117
153 AORTIC ARTERIOSCLEROSIS 30 0.0116
154 ORTHOPNOEA 37 0.0116
155 IMMUNE-MEDIATED MYOSITIS 32 0.0116
156 PEMPHIGOID 87 0.0115
157 BLOOD POTASSIUM INCREASED 187 0.0115
158 STAPHYLOCOCCAL BACTERAEMIA 50 0.0115
159 DYSURIA 423 0.0115
160 CANDIDA INFECTION 194 0.0115
161 RED CELL DISTRIBUTION WIDTH INCREASED 47 0.0113
162 ABSCESS LIMB 48 0.0113
163 RESPIRATORY ACIDOSIS 44 0.0112
164 PANCREATITIS 591 0.0112
165 ANAL ABSCESS 60 0.0111
166 CORONARY ARTERY BYPASS 64 0.0111
167 LEFT VENTRICULAR FAILURE 38 0.0110
168 PROSTATOMEGALY 43 0.0109
169 NEAR DEATH EXPERIENCE 36 0.0109
170 FUNGAL SKIN INFECTION 44 0.0109
171 PERIPHERAL ISCHAEMIA 44 0.0108
172 ANTINUCLEAR ANTIBODY POSITIVE 35 0.0108
173 LEFT VENTRICULAR HYPERTROPHY 46 0.0107
174 WEIGHT DECREASED 3000 0.0107
175 MITRAL VALVE INCOMPETENCE 121 0.0107
176 SEASONAL ALLERGY 149 0.0105
177 INFUSION SITE PAIN 135 0.0105
178 NOCTURIA 126 0.0104
179 IRON DEFICIENCY 46 0.0102
180 PANCREATITIS ACUTE 228 0.0101
181 PROTEIN URINE PRESENT 50 0.0100
182 VENTRICULAR HYPOKINESIA 32 0.0100
183 NEPHRITIS 33 0.0099
184 ERUCTATION 191 0.0099
185 HYPOPHAGIA 252 0.0098
186 TESTICULAR PAIN 31 0.0098
187 OLIGURIA 60 0.0097
188 LIPASE INCREASED 74 0.0096
189 BLOOD PRESSURE DIASTOLIC DECREASED 71 0.0096
190 ELECTROLYTE IMBALANCE 111 0.0095
191 CARDIAC DYSFUNCTION 35 0.0094
192 HYPOVOLAEMIC SHOCK 45 0.0094
193 TUBULOINTERSTITIAL NEPHRITIS 174 0.0093
194 BLOOD UREA INCREASED 155 0.0092
195 CHOLECYSTITIS 110 0.0092
196 VULVOVAGINAL BURNING SENSATION 56 0.0092
197 RENAL PAIN 97 0.0091
198 GASTROENTERITIS 133 0.0091
199 INFUSION SITE ERYTHEMA 76 0.0090
200 ANAL INCONTINENCE 81 0.0090
201 FLUID INTAKE REDUCED 45 0.0090
202 BLOOD CREATININE ABNORMAL 31 0.0090
203 ILEUS 111 0.0089
204 WEIGHT FLUCTUATION 92 0.0088
205 VULVOVAGINAL PAIN 42 0.0087
206 RENAL FUNCTION TEST ABNORMAL 40 0.0086
207 FULL BLOOD COUNT ABNORMAL 91 0.0086
208 HYPERTHYROIDISM 124 0.0086
209 BLOOD TRIGLYCERIDES INCREASED 151 0.0085
210 BENIGN PROSTATIC HYPERPLASIA 44 0.0085
211 DYSPNOEA EXERTIONAL 317 0.0084
212 MALNUTRITION 94 0.0084
213 FREQUENT BOWEL MOVEMENTS 226 0.0084
214 BLOOD URIC ACID INCREASED 48 0.0083
215 ENERGY INCREASED 49 0.0083
216 IMMUNE THROMBOCYTOPENIA 38 0.0083
217 ACUTE MYOCARDIAL INFARCTION 243 0.0082
218 INCONTINENCE 87 0.0082
219 URINARY INCONTINENCE 240 0.0081
220 CARDIAC PACEMAKER INSERTION 48 0.0080
221 HYPERPHAGIA 32 0.0080
222 SPINAL STENOSIS 33 0.0080
223 HUNGER 111 0.0080
224 RENAL IMPAIRMENT 667 0.0079
225 VENTRICULAR TACHYCARDIA 131 0.0079
226 SKIN ULCER 205 0.0079
227 PULSELESS ELECTRICAL ACTIVITY 33 0.0079
228 HAEMATURIA 269 0.0078
229 BLOOD IRON DECREASED 93 0.0078
230 SKIN ABRASION 37 0.0078
231 CORONARY ARTERY STENOSIS 39 0.0077
232 ATRIAL FIBRILLATION 753 0.0077
233 HYPOACUSIS 332 0.0077
234 BLOOD PRESSURE SYSTOLIC INCREASED 150 0.0077
235 SEPSIS 849 0.0076
236 DIABETES MELLITUS 580 0.0076
237 ALTERED STATE OF CONSCIOUSNESS 164 0.0076
238 JOINT EFFUSION 52 0.0075
239 BLOOD CREATININE INCREASED 491 0.0075
240 RENAL DISORDER 349 0.0075
241 INFUSION SITE SWELLING 47 0.0075
242 FLANK PAIN 70 0.0075
243 ACCIDENTAL OVERDOSE 273 0.0075
244 HYPOTENSION 1496 0.0075
245 BLOOD URINE PRESENT 141 0.0074
246 ADRENAL INSUFFICIENCY 90 0.0074
247 CEREBRAL INFARCTION 181 0.0074
248 BLOOD CHOLESTEROL ABNORMAL 34 0.0074
249 VENTRICULAR EXTRASYSTOLES 76 0.0073
250 LIMB INJURY 198 0.0073
251 HYPERVENTILATION 42 0.0072
252 SENSITIVITY TO WEATHER CHANGE 38 0.0072
253 TRICUSPID VALVE INCOMPETENCE 57 0.0072
254 HAEMORRHOIDAL HAEMORRHAGE 35 0.0072
255 SWOLLEN TONGUE 223 0.0071
256 TACHYPNOEA 97 0.0071
257 CONCOMITANT DISEASE AGGRAVATED 44 0.0071
258 TASTE DISORDER 144 0.0071
259 HEPATIC STEATOSIS 132 0.0071
260 ACCIDENTAL UNDERDOSE 102 0.0071
261 RALES 41 0.0071
262 FLUID RETENTION 359 0.0071
263 PRODUCT RESIDUE PRESENT 38 0.0070
264 BLOOD PRESSURE DECREASED 468 0.0070
265 IRON DEFICIENCY ANAEMIA 65 0.0070
266 ILLNESS 722 0.0070
267 HYPERTRIGLYCERIDAEMIA 41 0.0070
268 DECUBITUS ULCER 57 0.0070
269 CATHETERISATION CARDIAC 31 0.0070
270 ATRIOVENTRICULAR BLOCK 54 0.0070
271 CORONARY ARTERY OCCLUSION 95 0.0069
272 CYSTITIS 220 0.0069
273 CORONARY ARTERIAL STENT INSERTION 35 0.0069
274 MUSCLE ATROPHY 87 0.0069
275 INFLAMMATORY MARKER INCREASED 34 0.0069
276 UMBILICAL HERNIA 32 0.0068
277 FOOD CRAVING 36 0.0068
278 ANGINA PECTORIS 196 0.0068
279 IMPAIRED WORK ABILITY 146 0.0068
280 ESCHERICHIA INFECTION 56 0.0068
281 COVID-19 1194 0.0068
282 OVERWEIGHT 36 0.0067
283 DYSLIPIDAEMIA 34 0.0067
284 DECREASED APPETITE 1548 0.0067
285 GASTROINTESTINAL SOUNDS ABNORMAL 33 0.0067
286 INTENTIONAL PRODUCT USE ISSUE 579 0.0066
287 GROIN PAIN 58 0.0066
288 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 317 0.0066
289 HYDRONEPHROSIS 49 0.0065
290 RENAL TUBULAR NECROSIS 64 0.0065
291 LEUKOCYTOSIS 118 0.0065
292 PRODUCT PRESCRIBING ERROR 155 0.0065
293 PRODUCT ADMINISTRATION INTERRUPTED 51 0.0065
294 ARTERIAL OCCLUSIVE DISEASE 51 0.0065
295 NECROSIS 36 0.0065
296 LOCALISED INFECTION 156 0.0064
297 COVID-19 PNEUMONIA 76 0.0064
298 CORONARY ARTERY DISEASE 194 0.0064
299 BRAIN FOG 100 0.0064
300 KIDNEY INFECTION 125 0.0064
301 PROTEINURIA 121 0.0064
302 CARDIOMYOPATHY 93 0.0063
303 OSTEOMYELITIS 113 0.0062
304 BLOOD PRESSURE ABNORMAL 124 0.0062
305 VENTRICULAR FIBRILLATION 69 0.0062
306 ARTERIOSCLEROSIS CORONARY ARTERY 41 0.0062
307 CARDIAC FLUTTER 40 0.0062
308 CHOLELITHIASIS 202 0.0062
309 ANURIA 53 0.0062
310 SLEEP APNOEA SYNDROME 117 0.0061
311 OXYGEN SATURATION DECREASED 343 0.0061
312 PRESYNCOPE 148 0.0061
313 HAEMOGLOBIN ABNORMAL 39 0.0061
314 FLATULENCE 342 0.0060
315 ACUTE RESPIRATORY FAILURE 115 0.0060
316 VOMITING 2802 0.0060
317 SEPTIC SHOCK 259 0.0059
318 CARDIOGENIC SHOCK 85 0.0059
319 BLOOD POTASSIUM DECREASED 178 0.0059
320 PULMONARY CONGESTION 78 0.0059
321 ORTHOSTATIC HYPOTENSION 103 0.0059
322 HAEMATOCHEZIA 324 0.0059
323 ELECTROCARDIOGRAM ABNORMAL 46 0.0059
324 PULMONARY HYPERTENSION 122 0.0059
325 HEPATIC CIRRHOSIS 110 0.0058
326 TYPE 2 DIABETES MELLITUS 197 0.0058
327 CONSTIPATION 1276 0.0058
328 ATRIOVENTRICULAR BLOCK COMPLETE 39 0.0058
329 CHOLECYSTITIS ACUTE 33 0.0058
330 FOOD POISONING 31 0.0058
331 BLOOD SODIUM DECREASED 109 0.0058
332 SPINAL OPERATION 71 0.0058
333 DYSPEPSIA 565 0.0057
334 ABDOMINAL DISCOMFORT 963 0.0057
335 APPETITE DISORDER 38 0.0057
336 SKIN LACERATION 62 0.0057
337 CONCUSSION 44 0.0057
338 TYPE 1 DIABETES MELLITUS 34 0.0056
339 ARTERIOSCLEROSIS 53 0.0056
340 CEREBROVASCULAR ACCIDENT 953 0.0056
341 SPUTUM DISCOLOURED 53 0.0056
342 DIZZINESS 2775 0.0056
343 ATRIAL FLUTTER 44 0.0055
344 VERTIGO 336 0.0055
345 DRY THROAT 56 0.0055
346 PRODUCTIVE COUGH 263 0.0055
347 EXTRA DOSE ADMINISTERED 223 0.0055
348 C-REACTIVE PROTEIN INCREASED 200 0.0055
349 HICCUPS 45 0.0055
350 CYST 68 0.0055
351 PROCTALGIA 35 0.0054
352 CARDIAC DISORDER 508 0.0054
353 OROPHARYNGEAL DISCOMFORT 49 0.0054
354 FEEDING DISORDER 110 0.0054
355 POST PROCEDURAL INFECTION 44 0.0054
356 DEMENTIA 151 0.0054
357 CARDIAC FAILURE CONGESTIVE 432 0.0054
358 ODYNOPHAGIA 32 0.0054
359 GOUT 96 0.0053
360 PERIPHERAL SWELLING 818 0.0053
361 INTESTINAL OBSTRUCTION 200 0.0053
362 RENAL CYST 42 0.0053
363 DIARRHOEA 3406 0.0053
364 NEPHROLITHIASIS 242 0.0053
365 GENERALISED OEDEMA 65 0.0052
366 NEPHROPATHY 49 0.0052
367 PERIPHERAL COLDNESS 72 0.0052
368 GLUCOSE TOLERANCE IMPAIRED 31 0.0052
369 URINARY RETENTION 174 0.0052
370 MYOPATHY 45 0.0052
371 POST PROCEDURAL COMPLICATION 100 0.0052
372 DRY MOUTH 422 0.0052
373 CELLULITIS 262 0.0052
374 ACUTE CORONARY SYNDROME 43 0.0052
375 RECTAL HAEMORRHAGE 223 0.0052
376 PIGMENTATION DISORDER 32 0.0052
377 INCREASED APPETITE 99 0.0052
378 SHOCK 119 0.0052
379 ABDOMINAL PAIN 1201 0.0052
380 COUGH 1437 0.0051
381 SMALL INTESTINAL OBSTRUCTION 63 0.0051
382 MULTIPLE ALLERGIES 40 0.0051
383 ORAL CANDIDIASIS 67 0.0051
384 SCIATICA 81 0.0051
385 ABDOMINAL PAIN UPPER 1046 0.0051
386 ANGINA UNSTABLE 33 0.0051
387 HYPOKALAEMIA 234 0.0051
388 FURUNCLE 40 0.0050
389 CARDIOMEGALY 62 0.0050
390 INFARCTION 34 0.0050
391 OBESITY 79 0.0050
392 ARTHRITIS 390 0.0050
393 CHRONIC KIDNEY DISEASE 373 0.0049
394 MYOCARDIAL INFARCTION 856 0.0049
395 OCULAR DISCOMFORT 55 0.0049
396 BACTERAEMIA 58 0.0049
397 ABDOMINAL DISTENSION 510 0.0049
398 COLD SWEAT 86 0.0049
399 BLOOD PRESSURE FLUCTUATION 117 0.0049
400 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 876 0.0049
401 HYPERLIPIDAEMIA 58 0.0048
402 STENT PLACEMENT 39 0.0048
403 BLADDER DISORDER 48 0.0048
404 INABILITY TO AFFORD MEDICATION 48 0.0048
405 MYOCARDIAL ISCHAEMIA 55 0.0048
406 BOWEL MOVEMENT IRREGULARITY 37 0.0048
407 MEDICATION ERROR 268 0.0048
408 DECREASED ACTIVITY 52 0.0048
409 VITAMIN D DEFICIENCY 47 0.0048
410 CATARACT 286 0.0048
411 TENDERNESS 50 0.0048
412 HEART RATE DECREASED 168 0.0048
413 LOW DENSITY LIPOPROTEIN INCREASED 37 0.0048
414 NIGHTMARE 165 0.0048
415 COLITIS ULCERATIVE 213 0.0048
416 COLON CANCER 71 0.0048
417 LARGE INTESTINE POLYP 33 0.0048
418 GASTROENTERITIS VIRAL 86 0.0048
419 HYPERTRANSAMINASAEMIA 33 0.0047
420 PULMONARY OEDEMA 211 0.0047
421 NAUSEA 3728 0.0047
422 ECCHYMOSIS 32 0.0047
423 OEDEMA 253 0.0047
424 NERVE COMPRESSION 43 0.0047
425 RHINORRHOEA 300 0.0046
426 GASTROINTESTINAL PAIN 51 0.0046
427 JOINT INJURY 99 0.0046
428 TRANSIENT ISCHAEMIC ATTACK 155 0.0046
429 WRONG PRODUCT ADMINISTERED 31 0.0046
430 EPISTAXIS 343 0.0046
431 MYASTHENIA GRAVIS 37 0.0046
432 THERAPY CHANGE 45 0.0046
433 BLOOD THYROID STIMULATING HORMONE INCREASED 42 0.0046
434 DERMATITIS CONTACT 52 0.0046
435 HEART RATE IRREGULAR 103 0.0046
436 CHOLECYSTECTOMY 52 0.0045
437 ECZEMA 238 0.0045
438 DUODENAL ULCER 32 0.0045
439 PALPITATIONS 530 0.0045
440 ASTHENIA 1701 0.0045
441 BLOOD MAGNESIUM DECREASED 39 0.0045
442 GAIT INABILITY 151 0.0045
443 RETCHING 96 0.0045
444 ARRHYTHMIA 213 0.0045
445 TINNITUS 206 0.0045
446 BLOOD PRESSURE INCREASED 683 0.0045
447 DYSPNOEA 2526 0.0045
448 INJECTION SITE MASS 165 0.0045
449 OSTEOARTHRITIS 189 0.0045
450 HYPOMAGNESAEMIA 62 0.0044
451 MELAENA 98 0.0044
452 THERAPY INTERRUPTED 317 0.0044
453 FALL 1469 0.0044
454 RESPIRATORY TRACT CONGESTION 70 0.0044
455 RESPIRATORY RATE INCREASED 39 0.0044
456 NASAL CONGESTION 257 0.0044
457 EATING DISORDER 93 0.0044
458 WOUND 122 0.0044
459 CARPAL TUNNEL SYNDROME 61 0.0044
460 INCREASED TENDENCY TO BRUISE 40 0.0043
461 THERAPEUTIC RESPONSE UNEXPECTED 195 0.0043
462 THROAT IRRITATION 195 0.0043
463 PRODUCT DOSE OMISSION IN ERROR 123 0.0043
464 SURGERY 254 0.0043
465 HAEMODYNAMIC INSTABILITY 33 0.0043
466 HYPOPHOSPHATAEMIA 32 0.0043
467 AGEUSIA 108 0.0043
468 SYSTEMIC LUPUS ERYTHEMATOSUS 153 0.0043
469 BACTERIAL INFECTION 80 0.0043
470 HOT FLUSH 323 0.0043
471 VISUAL IMPAIRMENT 530 0.0043
472 LETHARGY 246 0.0043
473 RHABDOMYOLYSIS 178 0.0043
474 SPINAL PAIN 50 0.0043
475 ISCHAEMIC STROKE 76 0.0043
476 PRODUCT DOSE OMISSION ISSUE 1252 0.0043
477 INTENTIONAL DOSE OMISSION 121 0.0042
478 URINE OUTPUT DECREASED 37 0.0042
479 FACIAL PARALYSIS 36 0.0042
480 SLUGGISHNESS 43 0.0042
481 HAEMORRHOIDS 82 0.0042
482 HYPOXIA 148 0.0042
483 SENSITIVE SKIN 31 0.0042
484 CONTRAINDICATED PRODUCT ADMINISTERED 127 0.0042
485 PRODUCT COMMUNICATION ISSUE 37 0.0042
486 SYNCOPE 419 0.0042
487 RIB FRACTURE 86 0.0042
488 KNEE OPERATION 41 0.0042
489 SINUS DISORDER 82 0.0041
490 BLOOD CHOLESTEROL INCREASED 193 0.0041
491 BACK INJURY 45 0.0041
492 ABSCESS 66 0.0041
493 RENAL FAILURE 549 0.0041
494 POOR QUALITY SLEEP 89 0.0041
495 HYPERCALCAEMIA 51 0.0041
496 MUSCULOSKELETAL DISCOMFORT 71 0.0041
497 INSURANCE ISSUE 63 0.0041
498 EYE PAIN 232 0.0041
499 PELVIC FRACTURE 32 0.0041
500 PANCREATIC CARCINOMA 118 0.0041
501 CHROMATURIA 92 0.0041
502 EYE INFECTION 46 0.0041
503 GENERAL PHYSICAL HEALTH DETERIORATION 471 0.0041
504 VITREOUS FLOATERS 40 0.0041
505 WEIGHT INCREASED 911 0.0041
506 OEDEMA PERIPHERAL 495 0.0041
507 BACK DISORDER 66 0.0041
508 PRODUCT ADMINISTRATION ERROR 82 0.0041
509 SKIN DISORDER 135 0.0040
510 HEART RATE INCREASED 400 0.0040
511 ABNORMAL FAECES 33 0.0040
512 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114 0.0040
513 PERICARDIAL EFFUSION 93 0.0040
514 ASPIRATION 44 0.0040
515 GASTROOESOPHAGEAL REFLUX DISEASE 323 0.0040
516 HYPONATRAEMIA 226 0.0040
517 PRESCRIBED UNDERDOSE 80 0.0040
518 PRODUCT ODOUR ABNORMAL 42 0.0040
519 UPPER-AIRWAY COUGH SYNDROME 33 0.0040
520 DELIRIUM 139 0.0040
521 THERAPY NON-RESPONDER 180 0.0040
522 PNEUMONIA ASPIRATION 100 0.0040
523 BLOOD CALCIUM INCREASED 35 0.0040
524 BRAIN INJURY 40 0.0040
525 HEAD INJURY 126 0.0040
526 VITAMIN D DECREASED 34 0.0040
527 ROTATOR CUFF SYNDROME 51 0.0040
528 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35 0.0040
529 THERAPY CESSATION 203 0.0040
530 TENDONITIS 61 0.0039
531 CIRCULATORY COLLAPSE 67 0.0039
532 CONFUSIONAL STATE 634 0.0039
533 FATIGUE 3031 0.0039
534 PHARYNGEAL SWELLING 38 0.0039
535 PRODUCT USE COMPLAINT 61 0.0039
536 POOR VENOUS ACCESS 40 0.0039
537 HYPOKINESIA 56 0.0039
538 PSEUDOMONAS INFECTION 33 0.0038
539 TACHYCARDIA 341 0.0038
540 FRUSTRATION TOLERANCE DECREASED 31 0.0038
541 PAIN IN EXTREMITY 1128 0.0038
542 CHEST DISCOMFORT 390 0.0038
543 GASTROINTESTINAL DISORDER 339 0.0038
544 DYSGEUSIA 281 0.0038
545 INJECTION SITE HAEMORRHAGE 302 0.0038
546 LIMB DISCOMFORT 117 0.0038
547 SKIN HAEMORRHAGE 56 0.0038
548 FEELING JITTERY 72 0.0038
549 LOSS OF CONSCIOUSNESS 480 0.0037
550 BACK PAIN 862 0.0037
551 BLINDNESS 151 0.0037
552 RETINAL DETACHMENT 34 0.0037
553 SCRATCH 39 0.0037
554 FAECES DISCOLOURED 80 0.0037
555 CHEST PAIN 683 0.0037
556 EYE SWELLING 137 0.0037
557 MUSCULAR WEAKNESS 418 0.0037
558 PRODUCT DISTRIBUTION ISSUE 34 0.0037
559 VAGINAL DISCHARGE 37 0.0037
560 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 62 0.0036
561 TOOTHACHE 66 0.0036
562 NEUROPATHY PERIPHERAL 346 0.0036
563 HYPERHIDROSIS 468 0.0036
564 PROSTATIC SPECIFIC ANTIGEN INCREASED 50 0.0036
565 PRURITUS 1393 0.0036
566 UPPER LIMB FRACTURE 72 0.0036
567 KNEE ARTHROPLASTY 76 0.0036
568 PNEUMONIA BACTERIAL 33 0.0036
569 PARKINSONISM 35 0.0036
570 APHONIA 50 0.0036
571 MUSCLE TIGHTNESS 58 0.0036
572 SOMNOLENCE 720 0.0036
573 DEVICE LEAKAGE 155 0.0036
574 PNEUMONIA 1157 0.0036
575 DIVERTICULITIS 99 0.0036
576 GASTROINTESTINAL INFECTION 32 0.0036
577 SARS-COV-2 TEST POSITIVE 47 0.0036
578 PULMONARY MASS 53 0.0036
579 DEEP VEIN THROMBOSIS 231 0.0036
580 HYPERTENSION 751 0.0035
581 ERECTILE DYSFUNCTION 91 0.0035
582 OROPHARYNGEAL PAIN 327 0.0035
583 INTERNAL HAEMORRHAGE 40 0.0035
584 PAIN IN JAW 99 0.0035
585 MUSCULOSKELETAL CHEST PAIN 54 0.0035
586 BLINDNESS UNILATERAL 49 0.0035
587 INCORRECT DOSE ADMINISTERED BY DEVICE 91 0.0035
588 BODY TEMPERATURE DECREASED 34 0.0035
589 PLATELET COUNT INCREASED 45 0.0034
590 FEELING COLD 96 0.0034
591 MEMORY IMPAIRMENT 473 0.0034
592 DRUG EFFECT LESS THAN EXPECTED 51 0.0034
593 MALAISE 1507 0.0034
594 VASCULITIS 40 0.0034
595 SECRETION DISCHARGE 43 0.0034
596 SNEEZING 77 0.0034
597 APPENDICITIS 32 0.0034
598 POLYNEUROPATHY 41 0.0034
599 WHEEZING 203 0.0034
600 INJECTION SITE DISCOMFORT 36 0.0034
601 GASTRITIS 90 0.0034
602 DYSPHONIA 200 0.0034
603 BRADYCARDIA 181 0.0034
604 SINUS CONGESTION 46 0.0034
605 OESOPHAGITIS 37 0.0034
606 VISION BLURRED 464 0.0034
607 GASTRIC ULCER 64 0.0034
608 INJECTION SITE NODULE 37 0.0034
609 FACIAL PAIN 30 0.0034
610 PLEURAL EFFUSION 204 0.0033
611 DRUG-INDUCED LIVER INJURY 105 0.0033
612 ANGIOEDEMA 148 0.0033
613 INFLUENZA 373 0.0033
614 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 174 0.0033
615 DISORIENTATION 132 0.0033
616 OFF LABEL USE 2916 0.0033
617 CARDIAC ARREST 274 0.0033
618 ATELECTASIS 32 0.0033
619 WHITE BLOOD CELL COUNT INCREASED 127 0.0033
620 LACRIMATION INCREASED 100 0.0033
621 HIP FRACTURE 106 0.0033
622 WOUND INFECTION 36 0.0033
623 LUNG DISORDER 161 0.0033
624 SUBDURAL HAEMATOMA 47 0.0033
625 ABDOMINAL PAIN LOWER 83 0.0033
626 HAEMATOCRIT DECREASED 65 0.0033
627 DRUG ERUPTION 58 0.0033
628 PULMONARY EMBOLISM 311 0.0033
629 PALLOR 89 0.0033
630 TOOTH FRACTURE 36 0.0033
631 HEADACHE 2047 0.0033
632 NEEDLE ISSUE 95 0.0033
633 LIVER FUNCTION TEST INCREASED 70 0.0033
634 RED BLOOD CELL COUNT DECREASED 93 0.0032
635 DRUG INTERACTION 516 0.0032
636 NEURALGIA 79 0.0032
637 HYPERSOMNIA 93 0.0032
638 NERVE INJURY 36 0.0032
639 LIGAMENT SPRAIN 32 0.0032
640 INFLAMMATION 167 0.0032
641 DEPRESSED LEVEL OF CONSCIOUSNESS 128 0.0032
642 LOWER LIMB FRACTURE 62 0.0032
643 SKIN FISSURES 63 0.0032
644 MYALGIA 547 0.0032
645 INITIAL INSOMNIA 33 0.0032
646 PNEUMOTHORAX 51 0.0032
647 MIDDLE INSOMNIA 60 0.0032
648 DEVICE MECHANICAL ISSUE 44 0.0032
649 CLOSTRIDIUM DIFFICILE COLITIS 34 0.0032
650 ULCER 51 0.0032
651 FEELING ABNORMAL 768 0.0032
652 GAIT DISTURBANCE 608 0.0032
653 PULMONARY ARTERIAL HYPERTENSION 46 0.0032
654 HEPATIC ENZYME INCREASED 216 0.0032
655 PRODUCT PRESCRIBING ISSUE 69 0.0032
656 FOOT DEFORMITY 35 0.0032
657 DYSPHAGIA 299 0.0031
658 NASOPHARYNGITIS 580 0.0031
659 SWELLING 293 0.0031
660 QUALITY OF LIFE DECREASED 42 0.0031
661 DEVICE OCCLUSION 44 0.0031
662 PRODUCT DISPENSING ERROR 68 0.0031
663 SKIN INFECTION 35 0.0031
664 INJECTION SITE BRUISING 248 0.0031
665 ROAD TRAFFIC ACCIDENT 130 0.0031
666 HERNIA 60 0.0031
667 INFECTION 449 0.0031
668 MUSCLE SPASMS 569 0.0031
669 UPPER RESPIRATORY TRACT INFECTION 143 0.0031
670 BASAL CELL CARCINOMA 48 0.0031
671 EYE HAEMORRHAGE 41 0.0031
672 BLOOD TEST ABNORMAL 43 0.0031
673 ARTHRALGIA 1272 0.0031
674 ANKLE FRACTURE 47 0.0030
675 EYE PRURITUS 102 0.0030
676 RESPIRATORY TRACT INFECTION 79 0.0030
677 RASH MACULAR 106 0.0030
678 BALANCE DISORDER 262 0.0030
679 ORAL DISCOMFORT 42 0.0030
680 RASH 1313 0.0030
681 NEOPLASM MALIGNANT 201 0.0030
682 GLAUCOMA 58 0.0030
683 NIGHT SWEATS 97 0.0030
684 MIGRAINE 287 0.0030
685 INCORRECT DOSE ADMINISTERED 685 0.0030
686 INJECTION SITE EXTRAVASATION 37 0.0030
687 HAEMATEMESIS 76 0.0030
688 DENTAL CARIES 33 0.0030
689 JOINT RANGE OF MOTION DECREASED 40 0.0030
690 INTERVERTEBRAL DISC PROTRUSION 65 0.0030
691 LIP SWELLING 99 0.0030
692 NECK PAIN 166 0.0030
693 OBSTRUCTIVE AIRWAYS DISORDER 33 0.0030
694 HYPERTENSIVE CRISIS 33 0.0030
695 SWELLING FACE 193 0.0030
696 SLEEP DISORDER 209 0.0030
697 CARDIOVASCULAR DISORDER 75 0.0030
698 ORAL PAIN 66 0.0029
699 DERMATITIS ALLERGIC 37 0.0029
700 CONDITION AGGRAVATED 894 0.0029
701 ACCIDENT 35 0.0029
702 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 593 0.0029
703 BODY HEIGHT DECREASED 31 0.0029
704 SCAB 33 0.0029
705 BEDRIDDEN 38 0.0029
706 DEPRESSION 657 0.0029
707 DISCOMFORT 176 0.0029
708 CHILLS 338 0.0029
709 LOWER RESPIRATORY TRACT INFECTION 131 0.0029
710 FIBROMYALGIA 70 0.0029
711 DISTURBANCE IN ATTENTION 154 0.0029
712 PARAESTHESIA ORAL 41 0.0028
713 THERAPY PARTIAL RESPONDER 44 0.0028
714 STAPHYLOCOCCAL INFECTION 93 0.0028
715 TOOTH EXTRACTION 35 0.0028
716 DIPLOPIA 73 0.0028
717 IMPAIRED HEALING 92 0.0028
718 BRONCHITIS 207 0.0028
719 TREATMENT NONCOMPLIANCE 153 0.0028
720 DRUG LEVEL INCREASED 46 0.0028
721 ASTHMA 314 0.0028
722 INTENTIONAL PRODUCT MISUSE 243 0.0028
723 DYSSTASIA 81 0.0028
724 JOINT SWELLING 334 0.0028
725 HYPOAESTHESIA 414 0.0028
726 BLISTER 155 0.0028
727 CONTUSION 265 0.0027
728 HYPOCALCAEMIA 52 0.0027
729 SINUS TACHYCARDIA 39 0.0027
730 FOOT FRACTURE 52 0.0027
731 ANAEMIA 523 0.0027
732 TREMOR 455 0.0027
733 HAEMATOMA 71 0.0027
734 ADVERSE DRUG REACTION 246 0.0027
735 EYE DISORDER 90 0.0027
736 PSORIATIC ARTHROPATHY 111 0.0027
737 SPLENOMEGALY 32 0.0027
738 TOOTH INFECTION 36 0.0027
739 CEREBRAL HAEMORRHAGE 97 0.0027
740 PROCEDURAL PAIN 75 0.0027
741 HIATUS HERNIA 35 0.0027
742 SKIN DISCOLOURATION 124 0.0027
743 THROMBOSIS 216 0.0027
744 PRODUCT USE IN UNAPPROVED INDICATION 661 0.0027
745 PYREXIA 921 0.0027
746 ANKYLOSING SPONDYLITIS 35 0.0027
747 BODY TEMPERATURE INCREASED 54 0.0026
748 MOBILITY DECREASED 190 0.0026
749 RESTLESS LEGS SYNDROME 48 0.0026
750 DRUG INTOLERANCE 254 0.0026
751 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 45 0.0026
752 SKIN LESION 72 0.0026
753 APHASIA 79 0.0026
754 UPPER GASTROINTESTINAL HAEMORRHAGE 44 0.0026
755 VIRAL INFECTION 87 0.0026
756 LABORATORY TEST ABNORMAL 77 0.0026
757 HYPOTHYROIDISM 83 0.0026
758 TENDON RUPTURE 32 0.0026
759 HYPOAESTHESIA ORAL 39 0.0026
760 DISABILITY 51 0.0026
761 EYE IRRITATION 148 0.0026
762 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 120 0.0026
763 DEVICE FAILURE 39 0.0026
764 MENTAL STATUS CHANGES 71 0.0026
765 BURNING SENSATION 179 0.0026
766 AMNESIA 166 0.0025
767 HIP ARTHROPLASTY 39 0.0025
768 DIALYSIS 36 0.0025
769 ANAPHYLACTIC REACTION 140 0.0025
770 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 180 0.0025
771 THYROID DISORDER 39 0.0025
772 AGRANULOCYTOSIS 47 0.0025
773 RENAL INJURY 75 0.0025
774 EOSINOPHILIA 44 0.0025
775 RESPIRATORY FAILURE 183 0.0025
776 INJECTION SITE PRURITUS 168 0.0025
777 SINUSITIS 257 0.0025
778 THERAPEUTIC RESPONSE SHORTENED 83 0.0025
779 BLOOD CREATINE PHOSPHOKINASE INCREASED 72 0.0025
780 INJECTION SITE PAIN 767 0.0025
781 COMA 119 0.0025
782 PHOTOPHOBIA 47 0.0025
783 BLOOD ALKALINE PHOSPHATASE INCREASED 62 0.0025
784 SYNOVITIS 45 0.0025
785 HEAD DISCOMFORT 44 0.0025
786 THROAT TIGHTNESS 67 0.0025
787 PSORIASIS 323 0.0025
788 PSYCHOTIC DISORDER 73 0.0025
789 SKIN EXFOLIATION 207 0.0025
790 NERVOUSNESS 128 0.0024
791 CHOLESTASIS 47 0.0024
792 LIVER INJURY 60 0.0024
793 DEPRESSED MOOD 129 0.0024
794 RASH PRURITIC 132 0.0024
795 UVEITIS 33 0.0024
796 FRACTURE 46 0.0024
797 HALLUCINATION 182 0.0024
798 DRY SKIN 321 0.0024
799 DRY EYE 120 0.0024
800 HAEMOPTYSIS 67 0.0024
801 APATHY 35 0.0024
802 PAIN 1468 0.0024
803 INSOMNIA 636 0.0024
804 SPEECH DISORDER 125 0.0024
805 OCULAR HYPERAEMIA 113 0.0024
806 LIVER DISORDER 105 0.0024
807 MOVEMENT DISORDER 76 0.0024
808 HAEMOGLOBIN DECREASED 243 0.0024
809 SPINAL FRACTURE 47 0.0023
810 ALANINE AMINOTRANSFERASE INCREASED 144 0.0023
811 GINGIVAL BLEEDING 32 0.0023
812 ACUTE HEPATIC FAILURE 32 0.0023
813 FEELING HOT 143 0.0023
814 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 60 0.0023
815 UNRESPONSIVE TO STIMULI 60 0.0023
816 BRONCHOSPASM 33 0.0023
817 MOOD ALTERED 63 0.0023
818 RESPIRATORY DISORDER 69 0.0023
819 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51 0.0023
820 DEAFNESS 60 0.0023
821 PRODUCT AVAILABILITY ISSUE 52 0.0023
822 SCAR 39 0.0023
823 HERPES ZOSTER 130 0.0023
824 MUSCULOSKELETAL STIFFNESS 197 0.0022
825 COLITIS 84 0.0022
826 IMMUNODEFICIENCY 33 0.0022
827 EAR PAIN 43 0.0022
828 CLOSTRIDIUM DIFFICILE INFECTION 48 0.0022
829 PULMONARY FIBROSIS 42 0.0022
830 INJECTION SITE WARMTH 45 0.0022
831 DEVICE ISSUE 196 0.0022
832 GALLBLADDER DISORDER 39 0.0022
833 INTERSTITIAL LUNG DISEASE 105 0.0022
834 DISEASE RECURRENCE 103 0.0022
835 UNDERDOSE 158 0.0022
836 PRODUCT USE ISSUE 405 0.0022
837 LYMPHOCYTE COUNT DECREASED 38 0.0021
838 PELVIC PAIN 39 0.0021
839 PLATELET COUNT DECREASED 228 0.0021
840 JOINT STIFFNESS 56 0.0021
841 DEVICE DEFECTIVE 37 0.0021
842 PRODUCT PHYSICAL ISSUE 43 0.0021
843 GASTRIC DISORDER 73 0.0021
844 URTICARIA 355 0.0021
845 DEVICE DELIVERY SYSTEM ISSUE 58 0.0021
846 BLOOD BILIRUBIN INCREASED 57 0.0021
847 COAGULOPATHY 35 0.0021
848 PNEUMONITIS 57 0.0021
849 PERICARDITIS 35 0.0021
850 DEVICE MALFUNCTION 146 0.0021
851 COGNITIVE DISORDER 97 0.0021
852 ANOSMIA 30 0.0021
853 ILL-DEFINED DISORDER 125 0.0021
854 CHOKING 40 0.0020
855 HEPATIC FUNCTION ABNORMAL 76 0.0020
856 HEPATITIS 52 0.0020
857 EAR INFECTION 54 0.0020
858 END STAGE RENAL DISEASE 37 0.0020
859 ANXIETY 575 0.0020
860 HEMIPARESIS 34 0.0020
861 ALOPECIA 393 0.0020
862 PAIN OF SKIN 53 0.0020
863 ERYTHEMA 401 0.0019
864 HYPERSENSITIVITY 362 0.0019
865 DEVICE RELATED INFECTION 30 0.0019
866 PANIC ATTACK 71 0.0019
867 JAUNDICE 52 0.0019
868 BONE PAIN 113 0.0019
869 INFLUENZA LIKE ILLNESS 158 0.0019
870 RASH PAPULAR 43 0.0019
871 RESTLESSNESS 70 0.0019
872 IRRITABLE BOWEL SYNDROME 41 0.0019
873 ARTHROPATHY 106 0.0019
874 HOSPITALISATION 292 0.0019
875 DRUG INEFFECTIVE 2501 0.0019
876 METASTASES TO BONE 31 0.0019
877 DEVICE USE ISSUE 33 0.0019
878 RASH ERYTHEMATOUS 89 0.0019
879 SKIN CANCER 40 0.0019
880 DEATH 1600 0.0019
881 DYSARTHRIA 69 0.0018
882 HAEMORRHAGE 190 0.0018
883 FLUSHING 184 0.0018
884 GASTROINTESTINAL HAEMORRHAGE 151 0.0018
885 TOOTH DISORDER 40 0.0018
886 MENTAL DISORDER 78 0.0018
887 SUICIDAL IDEATION 164 0.0018
888 HEPATIC FAILURE 54 0.0018
889 ASPARTATE AMINOTRANSFERASE INCREASED 95 0.0018
890 INJECTION SITE SWELLING 137 0.0018
891 MUSCULOSKELETAL DISORDER 34 0.0018
892 PRODUCT DOSE OMISSION 115 0.0018
893 ACUTE RESPIRATORY DISTRESS SYNDROME 31 0.0018
894 LYMPHADENOPATHY 62 0.0017
895 ENCEPHALOPATHY 43 0.0017
896 PARAESTHESIA 275 0.0017
897 FULL BLOOD COUNT DECREASED 35 0.0017
898 ASCITES 51 0.0017
899 VAGINAL HAEMORRHAGE 75 0.0017
900 THROMBOCYTOPENIA 192 0.0017
901 INJECTION SITE URTICARIA 42 0.0017
902 ANAPHYLACTIC SHOCK 44 0.0017
903 LUNG NEOPLASM MALIGNANT 70 0.0017
904 ELECTROCARDIOGRAM QT PROLONGED 61 0.0017
905 STOMATITIS 102 0.0017
906 BLADDER CANCER 99 0.0017
907 RESPIRATORY ARREST 46 0.0017
908 MENTAL IMPAIRMENT 40 0.0016
909 FEMUR FRACTURE 51 0.0016
910 THERAPEUTIC PRODUCT EFFECT DECREASED 73 0.0016
911 ABNORMAL DREAMS 45 0.0016
912 INJECTION SITE RASH 50 0.0016
913 MUSCLE TWITCHING 37 0.0016
914 EXPIRED PRODUCT ADMINISTERED 53 0.0016
915 OSTEOPOROSIS 65 0.0016
916 SEIZURE 181 0.0016
917 MOUTH ULCERATION 33 0.0016
918 INJECTION SITE ERYTHEMA 191 0.0015
919 DERMATITIS 32 0.0015
920 DYSKINESIA 62 0.0015
921 INCORRECT PRODUCT ADMINISTRATION DURATION 33 0.0015
922 PRODUCT STORAGE ERROR 132 0.0015
923 CYTOKINE RELEASE SYNDROME 30 0.0015
924 RHEUMATOID ARTHRITIS 169 0.0015
925 RESPIRATORY DISTRESS 41 0.0015
926 LIVER FUNCTION TEST ABNORMAL 43 0.0015
927 WHITE BLOOD CELL COUNT DECREASED 160 0.0015
928 HALLUCINATION, VISUAL 31 0.0015
929 MUSCULOSKELETAL PAIN 76 0.0014
930 ANHEDONIA 38 0.0014
931 UNEVALUABLE EVENT 109 0.0014
932 RASH MACULO-PAPULAR 32 0.0014
933 EXPOSURE VIA SKIN CONTACT 37 0.0014
934 DERMATITIS ATOPIC 75 0.0014
935 AGGRESSION 71 0.0014
936 TOXICITY TO VARIOUS AGENTS 239 0.0014
937 FEBRILE NEUTROPENIA 94 0.0014
938 INTENTIONAL OVERDOSE 89 0.0014
939 MOOD SWINGS 44 0.0014
940 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 32 0.0014
941 CARDIO-RESPIRATORY ARREST 57 0.0014
942 SKIN IRRITATION 62 0.0014
943 THERAPEUTIC RESPONSE DECREASED 82 0.0014
944 IRRITABILITY 81 0.0013
945 PLASMA CELL MYELOMA 51 0.0013
946 FEAR 35 0.0013
947 DISEASE PROGRESSION 151 0.0013
948 EPILEPSY 38 0.0012
949 MALIGNANT NEOPLASM PROGRESSION 127 0.0012
950 AGITATION 91 0.0012
951 GASTRIC CANCER 31 0.0012
952 ANGER 41 0.0012
953 INFUSION RELATED REACTION 80 0.0012
954 BREAST CANCER 112 0.0012
955 ACNE 91 0.0012
956 PANCYTOPENIA 67 0.0012
957 NEUTROPHIL COUNT DECREASED 48 0.0012
958 ADVERSE EVENT 107 0.0012
959 DEVICE USE ERROR 40 0.0011
960 PRODUCT SUBSTITUTION ISSUE 66 0.0011
961 DEVICE DIFFICULT TO USE 71 0.0011
962 TREATMENT FAILURE 86 0.0010
963 NEUTROPENIA 141 0.0010
964 NERVOUS SYSTEM DISORDER 32 0.0010
965 VISUAL ACUITY REDUCED 34 0.0010
966 OSTEONECROSIS 33 0.0010
967 PROSTATE CANCER 80 0.0010
968 GYNAECOMASTIA 30 0.0010
969 SKIN BURNING SENSATION 69 0.0010
970 DEVICE BREAKAGE 39 0.0010
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50 0.0009
972 DRUG DOSE OMISSION BY DEVICE 70 0.0009
973 ACCIDENTAL EXPOSURE TO PRODUCT 92 0.0009
974 RENAL CANCER 42 0.0009
975 PRODUCT QUALITY ISSUE 117 0.0009
976 OVERDOSE 185 0.0009
977 MULTIPLE SCLEROSIS 40 0.0008
978 CRYING 30 0.0008
979 DEVICE DISLOCATION 35 0.0008
980 EMOTIONAL DISTRESS 95 0.0008
981 LEUKOPENIA 38 0.0008
982 INJECTION SITE REACTION 51 0.0007
983 INJURY 52 0.0007
984 NO ADVERSE EVENT 133 0.0007
985 COMPLETED SUICIDE 57 0.0007
986 SUICIDE ATTEMPT 38 0.0006
987 MULTIPLE SCLEROSIS RELAPSE 36 0.0005
988 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 37 0.0005
989 MATERNAL EXPOSURE DURING PREGNANCY 39 0.0004
990 DRUG ABUSE 36 0.0004
991 DRUG DOSE OMISSION 70 0.0004
992 DRUG DEPENDENCE 33 0.0002